98 SAFETY OF GUSELKUMAB IN PATIENTS AGED ≥60 YEARS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES: A POOLED ANALYSIS OF REGISTRATIONAL TRIALS IN UC, CD, PSA AND PSO
Adam S. Faye, Shaji Sebastian, Victoria McCaffrey, Ivana Bravatà et autres
0 citationsGastroenterology